Good day, 360!
Hope you were on Jeff’s list for his Bullseye Pick of the Week yesterday (TSLA) — what a banger — chat room going bonkers!
Don’t forget he’s live in the every Monday at 11AM EST in Market Masters. Be the best prepared trader on the Street!
FOCUS LIST🔎
TRNR – Up over 90% in the pre market after announcing it has successfully passed EU compliance for CLMBR and will start fulfilling European and UK orders immediately
MSS – Up over 100% in pre after reporting better than expected financial results
SLXN – Up over 44% in pre after announcing significant new data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer
*sponsored by CompareCredit
2 Cards Charging 0% Interest Until 2026
Paying down your credit card balance can be tough with the majority of your payment going to interest. Avoid interest charges for up to 18 months with these cards.
HOTLIST🔥
TRNR – Up over 90% in the pre market after announcing it has successfully passed EU compliance for CLMBR and will start fulfilling European and UK orders immediately
Interactive Strength Inc. (TRNR) doing business as FORME, operates a digital fitness platform that provides connected fitness hardware products and related accessories in the United States.
In the pre-market this morning, the company announced that CLMBR has passed EU-wide compliance requirements, has secured the mandatory CE marking and will begin fulfilling orders immediately from exclusive distributors in Germany, Switzerland and Austria.
The company also stated that:
Germany and the United Kingdom are two of the largest fitness markets globally
Third quarter revenue will be significantly higher than previous quarters
The stock traded up over 90% in the pre-market in reaction to the news.
The first target for bulls is the pre-market high at $0.48.
Above that, targets to the upside are $0.60, $0.68, $0.80 and $0.98.
Below $0.48, targets to the downside are $0.40, $0.30, $0.25 and then a gap fill at $0.2363.
MSS – Up over 100% in pre after reporting better than expected financial results
Maison Solutions Inc. (MSS) together with its subsidiaries, operates as a specialty grocery retailer in the United States.
In the after-hours yesterday, the company reported Q1 2025 results.
Highlights include:
Total net revenues for the first quarter increased 115.6% to $29.6 million compared to $13.8 million in the same period last fiscal year. The increase was primarily driven by the inclusion of revenues from the Company’s newly acquired subsidiary, Lee Lee Oriental Supermart, Inc. (“Lee Lee”) (acquired in April 2024), totaling $18.2 million.
Gross profit for the first quarter was $8.3 million, while gross margin was 27.9%. Gross profit for the same period last fiscal year was $3.1 million, while gross margin was 22.6%. The increase was primarily due to the higher gross profit from the Lee Lee stores.
Net income attributable to Maison Solutions for the first quarter was approximately $700,000, compared to a net loss of approximately $105,000 for the same period last fiscal year.
Fiscal Year 2025 Guidance
The Company is reiterating the following guidance for fiscal year 2025:
Revenues between $120 million and $125 million
Net income positive
The stock traded up over 100% in the pre-market in reaction to the positive earnings.
The $1.40 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $1.60, $1.80 and then the after-hours high at $1.94.
Below $1.40, targets to the downside are $1.20, $1, $0.90 and then a gap fill at $0.7150.
CONFUSED WHERE TO START???
Want to learn how to trade? We got that.
How to buy options? Sell options? We got that.
Long call spreads and butterfly trades? We got that….
And SO much more!
But if you’re confused about where to start with any of our services, why not give Davis a call today? He’d be happy to help you try to find the best fit —
Davis is standing by!
SLXN – Up over 44% in pre after announcing significant new data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer
Silexion Therapeutics Corp (SLXN) is a biopharmaceutical company that discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
In the pre-market this morning the company announced significant new data from its Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer.
Highlights include:
a 56% objective response rate (ORR) and 67% resectability improvement in non-resectable pancreatic cancer
This marks a significant step forward in potentially improving surgical outcomes for LAPC patients.
The stock traded up over 44% in the pre-market in reaction to the positive news.
The first target for nulls is the pre-market high at $1.39.
Beyond that, $1.70, $1.90 and $2.40 come into play.
Below $1.39, targets to the downside are $1.12, $1.03, $0.99, $0.90, $0.80 and then a gap fill at $0.7702.
MARKET NEWS 📰
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
